Sick Leave and Factors Influencing Sick Leave in Adult Patients with Atopic Dermatitis: A Cross-Sectional Study

por van Os-Medendorp, Harmieke, Appelman-Noordermeer, Simone, Bruijnzeel-Koomen, Carla, de Bruin-Weller, Marjolein
Publicado 2015

Usage and Users of Online Self-Management Programs for Adult Patients With Atopic Dermatitis and Food Allergy: An Explorative Study

por van Os-Medendorp, Harmieke, van Leent- de Wit, Ilse, de Bruin-Weller, Marjolein, Knulst, André
Publicado 2015

Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 Weeks

por Blauvelt, Andrew, de Bruin-Weller, Marjolein, Simpson, Eric L., Chen, Zhen, Zhang, Annie, Shumel, Brad
Publicado 2021

The long‐term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis—52 week results from the Dutch BioDay Registry

por Voorberg, Angelique N., Romeijn, Geertruida L. E., de Bruin‐Weller, Marjolein S., Schuttelaar, Marie L. A.
Publicado 2022

New Developments in Biomarkers for Atopic Dermatitis

por Thijs, Judith L., van Seggelen, Wouter, Bruijnzeel-Koomen, Carla, de Bruin-Weller, Marjolein, Hijnen, DirkJan
Publicado 2015

Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year

por Blauvelt, Andrew, de Bruin-Weller, Marjolein, Simpson, Eric L., Chen, Zhen, Ardeleanu, Marius, Rossi, Ana B.
Publicado 2022

Patient-Reported Ocular Disorders and Symptoms in Adults with Moderate-to-Severe Atopic Dermatitis: Screening and Baseline Survey Data from a Clinical Trial

por Weyne, Jonathan, Blauvelt, Andrew, de Bruin-Weller, Marjolein, Prens, Errol, Asbell, Penny, Sierka, Debra, Chen, Zhen, Shumel, Brad
Publicado 2020

Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis

por Silverberg, Jonathan I., Simpson, Eric L., Armstrong, April W., de Bruin-Weller, Marjolein S., Irvine, Alan D., Reich, Kristian
Publicado 2021

Food allergen sensitization pattern in adults in relation to severity of atopic dermatitis

por Röckmann, Heike, van Geel, Maartje J, Knulst, Andre C, Huiskes, Jorike, Bruijnzeel-Koomen, Carla AFM, de Bruin-Weller, Marjolein S
Publicado 2014

Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study

por Oosterhaven, Jart A.F., Voorberg, Angelique N., Romeijn, Geertruida L.E., de Bruin‐Weller, Marjolein S., Schuttelaar, Marie L.A.
Publicado 2019

Nomenclature and clinical phenotypes of atopic dermatitis

por Girolomoni, Giampiero, de Bruin-Weller, Marjolein, Aoki, Valeria, Kabashima, Kenji, Deleuran, Mette, Puig, Luis, Bansal, Ashish, Rossi, Ana B.
Publicado 2021

Economic and Humanistic Burden in Paediatric Patients with Atopic Dermatitis

por ACHTEN, Roselie, VAN DER RIJST, Lisa, PIENA, Marjanne, LAMERS, Hedda, DE BEER, Fleur, DE BRUIN-WELLER, Marjolein, DE GRAAF, Marlies
Publicado 2023

Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic Dermatitis

por Simpson, Eric L., de Bruin-Weller, Marjolein, Bansal, Ashish, Chen, Zhen, Nelson, Lauren, Whalley, Diane, Prescilla, Randy, Guillemin, Isabelle, Delevry, Dimittri
Publicado 2021

Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey

por AUGUSTIN, Matthias, COSTANZO, Antonio, PINK, Andrew, SENESCHAL, Julien, SCHUSTER, Christopher, MERT, Can, GUERREIRO, Mariana, TIETZ, Nicole, GROND, Susanne, DE BRUIN-WELLER, Marjolein
Publicado 2022

Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study

por Alexis, Andrew, de Bruin-Weller, Marjolein, Weidinger, Stephan, Soong, Weily, Barbarot, Sebastien, Ionita, Ileana, Zhang, Fan, Valdez, Hernan, Clibborn, Claire, Yin, Natalie
Publicado 2022

Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis

por de Bruin-Weller, Marjolein S., Serra-Baldrich, Esther, Barbarot, Sebastien, Grond, Susanne, Schuster, Christopher, Petto, Helmut, Capron, Jean-Philippe, Raibouaa, Afaf, Werfel, Thomas
Publicado 2022

Dupilumab facial redness: Positive effect of itraconazole

por de Beer, Fleur S.A., Bakker, Daphne S., Haeck, Inge, Ariens, Lieneke, van der Schaft, Jorien, van Dijk, Marijke R., de Bruin-Weller, Marjolein S.
Publicado 2019

Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective

por de Bruin-Weller, Marjolein, Merola, Joseph F., Hong, Chih-ho, Baldrich, Esther Serra, Ettler, Karel, Sierka, Debra, Delevry, Dimittri, Chen, Zhen, Rossi, Ana B.
Publicado 2021

Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16

por Thyssen, Jacob P., de Bruin-Weller, Marjolein, Costanzo, Antonio, Grond, Susanne, Schuster, Christopher, Liu, Chunyuan, Rueda, Maria Jose, Chen, Yun-Fei, Pinter, Andreas, Bieber, Thomas
Publicado 2023

Specific IgE to fish extracts does not predict allergy to specific species within an adult fish allergic population

por Schulkes, Karlijn JG, Klemans, Rob JB, Knigge, Lidy, de Bruin-Weller, Marjolein, Bruijnzeel-Koomen, Carla AFM, Marknell deWitt, Åsa, Lidholm, Jonas, Knulst, André C
Publicado 2014